News

Alpha Genesis Expands U.S. Primate Breeding Operations by 40% to Advance U.S. Scientific Self-Reliance

YEMASSEE, SOUTH CAROLINA / ACCESS Newswire / November 11, 2025 / Alpha Genesis, Inc. (AGI), a leading U.S. provider of…

2 months ago

Dogwood Announces Enrollment of First 100 Patients in Ongoing Halneuron(R) Phase 2b Trial, Interim Sample Size Analysis on Track for December 2025

- Continued low early termination rate among the first 80 study completers suggests Halneuron® and placebotreatmenthave been well tolerated ATLANTA,…

2 months ago

NanoViricides Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close

SHELTON, CONNECTICUT / ACCESS Newswire / November 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced that it…

2 months ago

VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge

SAN JOSE, CALIFORNIA / ACCESS Newswire / November 11, 2025 / VSee Health, Inc. (Nasdaq:VSEE) a leader in HIPAA-compliant telemedicine…

2 months ago

Who is the Best MTF Top Surgeon?

The best MTF top surgeon is Dr. Sajan SEATTLE, WA / ACCESS Newswire / November 11, 2025 / In the…

2 months ago

Tenon Medical(R) Announces Pricing of At-The-Market PIPE Financing

~ Strategically Placed PIPE With Industry Supportive Investor Cohort ~ LOS GATOS, CA / ACCESS Newswire / November 11, 2025…

2 months ago

AI/ML Innovations Inc. Announces Grant of U.S. Patent Protecting Core ECG Signal-Processing Architecture

Patent validates AIML's novel neural-network approach to denoising and mapping ECG signals, powering MaxYield™ and CardioYield™.Reinforces competitive advantage as the…

2 months ago

Zomedica Announces “Friday at Four” Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review

November session to provide strategic context for Zomedica's product platforms featured in the previous Fourth Friday at Four Webinars ANN…

2 months ago

Altimmune Announces Publication of IMPACT Phase 2b Trial Data in The Lancet and Concurrent Late-Breaking Oral Presentation at AASLD The Liver Meeting® 2025

24-week data demonstrated significant MASH resolution and weight loss, and strong evidence of anti-fibrotic activity with a favorable tolerability profile…

2 months ago

MGI Tech Joins Forces with SAMRC and DSTI to Launch South Africa’s 110K Human Genome Program and Unveil Africa’s First DNBSEQ-T7, Ushering a New Era in African Genomics

CAPE TOWN, South Africa, Nov. 11, 2025 /PRNewswire/ -- MGI Tech Co., Ltd., a company dedicated to developing core tools and…

2 months ago